Impact of the clinical frailty scale on clinical outcomes and bleeding events in patients with ST-segment elevation myocardial infarction.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 02 10 2020
accepted: 18 12 2020
pubmed: 8 1 2021
medline: 30 9 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

The Clinical Frailty Scale (CFS) is a simple tool to assess patients' frailty and may help to predict adverse outcomes in elderly patients. The aim of the present study was to examine the impact of CFS on clinical outcomes and bleeding events after successful percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI). We enrolled 266 consecutive patients with STEMI who underwent primary PCI in between January 2015 and June 2018. Patients were categorized into two groups based on the CFS stages: CFS 1-3 and CFS ≥ 4. We collected the data and evaluated the relationship between the CFS grade and the incidence of major adverse cardiovascular events (MACE) and Bleeding Academic Research Consortium 3 or 5 bleeding events. Of these patients, CFS ≥ 4 was present in 59 (22.2%). During the follow-up, 37.3% in the CFS ≥ 4 group and 8.2% in the CFS 1-3 group experienced MACE. In Kaplan-Meier analysis, the proportion of MACE-free survival for 4 years was significantly lower in the CFS ≥ 4 group (log-rank P < 0.001). Additionally, the proportion of bleeding event-free survival was significantly lower in the CFS ≥ 4 group (log-rank P < 0.001). The CFS (per 1-grade increase) remained an independent significant predictor of MACE on multivariate Cox proportional hazard analysis [hazard ratio 1.39 (95% confidence interval: 1.08 to 1.79, P = 0.01)]. In conclusion, CFS was an independent predictor of future adverse cardiac events in patients with STEMI. Therefore, the assessment of CFS is crucial in this population.

Identifiants

pubmed: 33411012
doi: 10.1007/s00380-020-01764-0
pii: 10.1007/s00380-020-01764-0
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-808

Références

Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA (2014) Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 63:747–762
doi: 10.1016/j.jacc.2013.09.070
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381:752–762
doi: 10.1016/S0140-6736(12)62167-9
Shamliyan T, Talley KM, Ramakrishnan R, Kane RL (2013) Association of frailty with survival: a systematic literature review. Ageing Res Rev 12:719–736
doi: 10.1016/j.arr.2012.03.001
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013) Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127:e6–e245
pubmed: 23239837
Gregorevic KJ, Hubbard RE, Lim WK, Katz B (2016) The clinical frailty scale predicts functional decline and mortality when used by junior medical staff: a prospective cohort study. BMC Geriatr 16:117
doi: 10.1186/s12877-016-0292-4
Clinical Frailty Scale–Geriatric Medicine Research–Dalhousie University. Faculty of Medicine, Geriatric Medicine Research, Research/Projects, Clinical Frailty Scale.Dalhousie University, Halifax, Canada. https://www.dal.ca/sites/gmr/our-tools/clinical-frailty-scale.html Accessed Sept 5, 2020
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173:489–495
doi: 10.1503/cmaj.050051
Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H, MIYAGI-AMI Study Investigators (2010) Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 74:93–100
doi: 10.1253/circj.CJ-09-0619
Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T, PACIFIC investigators, (2013) Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 77:934–943
doi: 10.1253/circj.CJ-13-0174
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782
doi: 10.1161/CIRCULATIONAHA.106.612812
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123:2736–2782
doi: 10.1161/CIRCULATIONAHA.110.009449
Tapanainen JM, Lindgren KS, Mäkikallio TH, Vuolteenaho O, Leppäluoto J, Huikuri HV (2004) Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 43:757–763
doi: 10.1016/j.jacc.2003.09.048
Costa D, Aladio M, Girado CA, Pérez de la Hoz R, Sara Berensztein C (2018) Frailty is independently associated with 1-year mortality after hospitalization for acute heart failure. Int J Cardiol Heart Vasc 21:103–106
pubmed: 30450408 pmcid: 6226571
Campbell AJ, Buchner DM (1997) Unstable disability and the fluctuations of frailty. Age Ageing 26:315–318
doi: 10.1093/ageing/26.4.315
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP (2002) Cardiovascular health study frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the cardiovascular health study. Arch Intern Med 162:2333–2341
doi: 10.1001/archinte.162.20.2333
Anker SD, Haehling SV (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464–470
doi: 10.1136/hrt.2002.007005
Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D’Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118:2057–2062
doi: 10.1161/CIRCULATIONAHA.108.784215
Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA (2009) Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 53:13–20
doi: 10.1016/j.jacc.2008.08.067
Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, Napoli N, Qualls C, Shah K (2011) Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 364:1218–1229
doi: 10.1056/NEJMoa1008234
Koifman E, Magalhaes MA, Ben-Dor I, Kiramijyan S, Escarcega RO, Fang C, Torguson R, Okubagzi P, Negi SI, Baker NC, Minha S, Corso PJ, Shults C, Satler LF, Pichard AD, Waksman R (2015) Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement. Am J Cardiol 115:1260–1264
doi: 10.1016/j.amjcard.2015.02.009
Wallace SM, Verbeeck RK (1987) Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 12:41–72
doi: 10.2165/00003088-198712010-00004
Taneja R, Yared JP, Hammel J, O’Connor MS, Insler S, Starr NJ (2001) Hyperdynamic circulation following cardiopulmonary bypass predisposes to postoperative bleeding. Crit Care 5:P110
doi: 10.1186/cc1177
Ekerstad N, Swahn E, Janzon M, Alfredsson J, Löfmark R, Lindenberger M, Carlsson P (2011) Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 124:2397–2404
doi: 10.1161/CIRCULATIONAHA.111.025452

Auteurs

Masanari Kurobe (M)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Yasuhiro Uchida (Y)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan. y-uchida1122@sepia.ocn.ne.jp.

Hideki Ishii (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Daiki Yamashita (D)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Jun Yonekawa (J)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Akinori Satake (A)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Yuichiro Makino (Y)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Takatsugu Hiramatsu (T)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Koji Mizutani (K)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Yoshiaki Mizutani (Y)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Hitoshi Ichimiya (H)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Tetsuya Amano (T)

Department of Cardiology, Aichi Medical University, Nagakute, Japan.

Junji Watanabe (J)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Masaaki Kanashiro (M)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Tatsuaki Matsubara (T)

Department of Internal Medicine, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.

Satoshi Ichimiya (S)

Department of Cardiology, Yokkaichi Municipal Hospital, 2-2-37, Shibata, Yokkaichi, 510-8567, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH